Log In
Print
BCIQ
Print
Print this Print this
 

BACE1 inhibitor (BI1181181, VTP-37948)

  Manage Alerts
Collapse Summary General Information
Company Vitae Pharmaceuticals Inc.
DescriptionBeta-site APP-cleaving enzyme 1 (BACE1) inhibitor
Molecular Target Beta-site APP-cleaving enzyme 1 (BACE1)
Mechanism of ActionBeta-site APP-cleaving enzyme 1 (BACE1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner

Boehringer Ingelheim GmbH


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today